TOKYO, Oct. 29 /PRNewswire/ -- Aloka Co., Ltd., the Innovator in Ultrasound for more than 50 years, announced today the introduction of two ultrasound systems with dedicated platforms for advanced cardiac and vascular imaging, the ProSound Alpha 10 and the ProSound Alpha 7 at Scientific Session 2007 of American Heart Association, at the Orange County Convention Center in Orlando, Florida, November 4-7, 2007.
The ProSound Alpha 7 and the Alpha 10 incorporate all of the standard cardiovascular features such as stress echo, Tissue Doppler Imaging, Strain Imaging, Transesophageal echocardiography, full reporting capabilities and IHE & DICOM networking.
With important breakthrough flow display technology, the systems offer Directional eFLOW, D-eFLOW, a new innovative blood flow capture & display mode offering increased accuracy in blood flow detection of low velocity flow as well as acute acceleration. A standard new feature in these systems is the "Edge Optimizer" function, which improves dramatically the edge differentiation without compromise in temporal resolution. With high image definition and temporal resolution, the new ProSound systems offer a new level of diagnostic imaging in echocardiography.
The ProSound alpha 7 and alpha 10 offer a comprehensive cardio vascular analysis package.
More than ever, the cardiology community is recognizing the correlation
between vascular diseases and the heart. The early detection of
atherosclerosis could play a key role in preventing coronary artery
disease, and peripheral arterial disease. Aloka has developed a technique
that not only helps with early detection, but even helps to identify
patients who are prone to atherosclerosis even before the usual clinical
symptoms appear eTRACKING(TM) -- Echo Tracking is a proven technique that
picks RF echo signals from blood vessels, tracks the motion of vessel
walls, and measures changes in blood vessel diameter. Important parameters
such as Pulse Wave Ve
|SOURCE Aloka Co., Ltd.|
Copyright©2007 PR Newswire.
All rights reserved